highperformr logo

Cantargia AB's Overview

Total employees30
HeadquartersLund
Founded2010

Cantargia AB (publ) is a clinical-stage biotechnology company dedicated to developing antibody-based therapies for life-threatening diseases, with a primary focus on cancer and inflammatory conditions. The company's research centers on the interleukin-1 receptor accessory protein (IL1RAP), a target molecule involved in various cancer forms and inflammatory processes. Cantargia's lead candidate, nadunolimab (CAN04), is being investigated in multiple clinical trials for various cancers, including pancreatic cancer, non-small cell lung cancer, and triple-negative breast cancer. A second project, CAN10, is an antibody targeting IL1RAP for the treatment of autoimmune and inflammatory diseases, currently in late preclinical development.

Where is Cantargia AB's Headquarters?

HQ Function

Serves as the central hub for research and development, clinical operations, corporate administration, financial management, and strategic business development.

Notable Features:

Located within Medicon Village, a leading Scandinavian life science park, offering access to advanced research infrastructure, shared lab facilities, and a collaborative ecosystem with other biotech companies and academic institutions.

Work Culture:

A dynamic, science-driven, and collaborative work environment. Cantargia fosters innovation, teamwork, and a strong focus on advancing treatments for patients with life-threatening diseases, encouraging scientific rigor and open communication.

HQ Significance:

The Lund headquarters is crucial for Cantargia's core research activities, management of its global clinical trial programs, intellectual property development, and strategic positioning within Europe's biotechnology landscape.

Values Reflected in HQ: The headquarters' location and setup reflect Cantargia's commitment to scientific excellence, cutting-edge innovation, collaboration with the broader scientific community, and a focused mission to deliver impactful therapies to patients.

Location:

Cantargia AB manages its global operations, primarily its extensive clinical development programs, from its headquarters in Lund, Sweden. The company collaborates with clinical trial sites, contract research organizations (CROs), and academic institutions across North America, Europe, and potentially other regions to advance its therapeutic candidates. Its engagement with regulatory authorities such as the FDA (USA) and EMA (Europe) also underscores its international operational scope. Business development activities are also global, seeking partnerships and collaborations worldwide.

Street Address:

Medicon Village, Scheeletorget 1

City:

Lund

State/Province:

Skåne County

Country:

Sweden

Cantargia AB's Global Presence

Buying Intent Signals for Cantargia AB

Highperformr Signals uncover buying intent and give you clear insights to target the right accounts at the right time — helping your sales, marketing, and GTM teams close more deals, faster.

Notable news
Hiring actively
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
Corporate Finance
*Example signal, not calculated in real time

Executive Team of Cantargia AB

As of April 2025, Cantargia AB' leadership includes:

Göran Forsberg - Chief Executive Officer (CEO)
Patrik Renblad - Chief Financial Officer (CFO)
David Liberg - Chief Scientific Officer (CSO)
Nadja Sörgärde - Chief Medical Officer (CMO)
Lars Thagesson - Head of Clinical Development
Alessandra Nurzia - Head of Regulatory Affairs

Investors of Cantargia AB

Cantargia AB has been backed by several prominent investors over the years, including:

Fjärde AP-fonden (Fourth AP Fund)
Avanza Pension
Swedbank Robur Fonder
Handelsbanken Fonder
Nordea Investment Funds
Första AP-fonden (First AP Fund)

Executive New Hires/Exits in the Last 12 Months

Hire1
Exits1

In the past 12 months, Cantargia AB appointed Patrik Renblad as the new Chief Financial Officer, succeeding Bengt Jöndell who retired from the position.

Departures

Bengt Jöndell, Bengt Jöndell retired as CFO.

New Appointments:

Patrik Renblad, Patrik Renblad appointed as new CFO, succeeding Bengt Jöndell.

Technology (Tech Stack) used by Cantargia AB

Discover the tools Cantargia AB uses. Highperformr reveals the technologies powering your target accounts — helping your sales, marketing, and GTM teams prioritize smarter and close faster.

Cantargia AB Email Formats and Examples

Cantargia AB typically uses the 'firstname.lastname@cantargia.com' email format for its employees. This is a common pattern for companies in Sweden and globally.

firstname.lastname@cantargia.com

Format

goran.forsberg@cantargia.com

Example

90%

Success rate

News and media

Cantargia AB Press ReleasesMay 23, 2024

Cantargia AB news title: Cantargia to present new nadunolimab efficacy data from the CANFOUR trial at the ASCO Annual Meeting

Cantargia announced it will present updated efficacy results from the CANFOUR phase IIb clinical trial, investigating nadunolimab plus chemotherapy in first-line pancreatic cancer (PDAC), at the ASCO Annual Meeting 2024....more

Cantargia AB Press ReleasesApril 25, 2024

Cantargia AB news title: Cantargia's Interim Report January - March 2024

Cantargia released its Q1 2024 financial results, highlighting progress in its clinical trials, particularly the CANFOUR study with nadunolimab, and advancements in the CAN10 project....more

Cantargia AB Press ReleasesApril 8, 2024

Cantargia AB news title: Cantargia presents new preclinical data for nadunolimab at the AACR Annual Meeting 2024, supporting novel mechanisms of action

Cantargia presented new preclinical findings at the American Association for Cancer Research (AACR) Annual Meeting 2024, further elucidating the mechanisms of action of its lead drug candidate nadunolimab (CAN04)....more

Highperformr’s free tools for company research

Explore Employees by Region or Country

See where a company’s workforce is located, by country or region.

View Funding Details

View past and recent funding rounds with amounts and investors.

Understand Revenue Insights

Understand company revenue estimates and financial scale.

Track Active Job Openings

Track active roles and hiring trends to spot growth signals.

Review Product and Offerings

Discover what a company offers—products, platforms, and solutions.

Get SIC or NAICS Codes

Get the company’s official SIC and NAICS classifications.

Analyze Website Traffic Trends

Analyze visitor volume, engagement, and top traffic sources.

Discover Social Profiles and Engagement

Explore LinkedIn, Twitter, and other active social profiles.

Identify Top Competitors

Identify top competitors based on similar business traits.

Research and Discover Companies with Highperformr — Smarter, Faster

Explore companies in depth — from the tech they use to recent funding, hiring trends, and buyer signals — all in one powerful view.

Highperformr AI helps you surface the right accounts and enrich your CRM with verified company and contact insights, so your teams can prioritize and engage faster.

  • Track intent signals to find buyers who are actively in-market
  • Enrich contacts and companies instantly, no need to switch tools
  • Automate workflows to stay ahead of every change
  • Connect your CRM & tools for seamless data sync and activation

Thousands of companies, including Cantargia AB, are just a search away.